AG
RMD icon

AIA Group’s ResMed RMD Stock Holding History

AIA Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,007
Closed -$593K – 299
2023
Q3 		$593K Sell
4,007
-2,095
-34% -$379K 0.03% 207
2023
Q2 		$1.33M Buy
6,102
+5,587
+1,085% +$1.25M 0.06% 142
2023
Q1 		$113K Sell
515
-128
-20% -$27.8K 0.01% 363
2022
Q4 		$134K Sell
643
-251
-28% -$55.1K 0.01% 354
2022
Q3 		$195K Sell
894
-551
-38% -$125K 0.01% 295
2022
Q2 		$303K Sell
1,445
-928
-39% -$198K 0.02% 302
2022
Q1 		$575K Buy
2,373
+765
+48% +$185K 0.03% 217
2021
Q4 		$419K Buy
1,608
+467
+41% +$121K 0.02% 196
2021
Q3 		$301K Buy
1,141
+160
+16% +$43.8K 0.02% 218
2021
Q2 		$249K Buy
+981
New +$206K 0.02% 196

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AIA Group's RMD Position: Q4 2023 in Review

AIA Group sold out of ResMed (RMD) in Q4 2023, closing a stake of 4,007 shares — an estimated $593K sold.

AIA Group first reported a position in RMD in Q2 2021 and held it in 10 quarters. The position peaked at $1.33M in Q2 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • AIA Group reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
  • AIA Group sold 4,007 ResMed shares in Q4 2023, an estimated $593K.
  • AIA Group first reported a position in ResMed in Q2 2021 and held it in 10 quarters.
  • AIA Group's ResMed position peaked at $1.33M in Q2 2023.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on AIA Group's 13F filing for Q4 2023, filed 31 Jan 2024.